When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HRTX - FDA rejects Heron's application for pain med HTX-011; shares down 1% premarket
Heron Therapeutics Inc.
Heron Therapeutics (NASDAQ:HRTX) has received a CRL from the FDA regarding its marketing application for HTX-011 for the management of postoperative pain.
More news on: Heron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,